日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Correction: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma

更正：用于局部治疗多发性骨髓瘤溶骨性骨病和微小残留病灶的硼替佐米释放二氧化硅-胶原蛋白干凝胶

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-025-01663-9
Hose, Dirk; Ray, Seemun; Rößler, Sina; Thormann, Ulrich; Schnettler, Reinhard; de Veirman, Kim; Khassawna, Thaqif El; Heiss, Christian; Hild, Anne; Zahner, Daniel; Alagboso, Francisca; Henss, Anja; Beck, Susanne; Emde-Rajaratnam, Martina; Burhenne, Jürgen; Bamberger, Juliane; Menu, Eline; de Bruyne, Elke; Gelinsky, Michael; Kampschulte, Marian; Rohnke, Marcus; Wenisch, Sabine; Vanderkerken, Karin; Hanke, Thomas; Seckinger, Anja; Alt, Volker
多发性骨髓瘤
骨髓瘤
发表日期：2025
文献求助 收藏

Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma

释放硼替佐米的二氧化硅胶原干凝胶局部治疗多发性骨髓瘤溶骨性骨病和微小残留病

期刊:Journal of Hematology & Oncology
影响因子:29.5
doi:10.1186/s13045-024-01636-4
Dirk Hose #, Seemun Ray #, Sina Rößler #, Ulrich Thormann #, Reinhard Schnettler, Kim de Veirman, Thaqif El Khassawna, Christian Heiss, Anne Hild, Daniel Zahner, Francisca Alagboso, Anja Henss, Susanne Beck, Martina Emde-Rajaratnam, Jürgen Burhenne, Juliane Bamberger, Eline Menu, Elke de Bruyne, Mic
肿瘤
骨髓瘤
发表日期：2024
文献求助 收藏

Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation

以硼替佐米为基础的诱导治疗、大剂量化疗和自体干细胞移植治疗的多发性骨髓瘤患者的定量整合生存预测

期刊:Jco Precision Oncology
影响因子:5.6
doi:10.1200/PO.23.00613
Hummel, Manuela; Hielscher, Thomas; Emde-Rajaratnam, Martina; Salwender, Hans; Beck, Susanne; Scheid, Christof; Bertsch, Uta; Goldschmidt, Hartmut; Jauch, Anna; Moreaux, Jérôme; Seckinger, Anja; Hose, Dirk
发育与干细胞
多发性骨髓瘤
骨髓瘤
干细胞
细胞生物学
发表日期：2024
文献求助 收藏

Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma-Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income Countries

GMMG-HD4试验在多发性骨髓瘤中的分子长期分析——染色体畸变与反应和增殖关联的模式，以及在资源有限的中低收入国家选择治疗方案时如何决定生存期

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms25126431
Seckinger, Anja; Salwender, Hans; Martin, Hans; Scheid, Christof; Hielscher, Thomas; Bertsch, Uta; Hummel, Manuela; Jauch, Anna; Knauf, Wolfgang; Emde-Rajaratnam, Martina; Beck, Susanne; Neben, Kai; Dührig, Jan; Lindemann, Walter; Schmidt-Wolf, Ingo G H; Hänel, Mathias; Blau, Igor W; Weisel, Katja; Weinhold, Niels; Raab, Marc S; Goldschmidt, Hartmut; Choon-Quinones, Mimi; Hose, Dirk
多发性骨髓瘤
骨髓瘤
发表日期：2024
文献求助 收藏

RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma

基于RNA测序的多发性骨髓瘤一线治疗方案选择及风险评估

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2023.1286700
Emde-Rajaratnam, Martina; Beck, Susanne; Benes, Vladimir; Salwender, Hans; Bertsch, Uta; Scheid, Christoph; Hänel, Mathias; Weisel, Katja; Hielscher, Thomas; Raab, Marc S; Goldschmidt, Hartmut; Jauch, Anna; Maes, Ken; De Bruyne, Elke; Menu, Eline; De Veirman, Kim; Moreaux, Jérôme; Vanderkerken, Karin; Seckinger, Anja; Hose, Dirk
多发性骨髓瘤
骨髓瘤
发表日期：2023
文献求助 收藏

MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma

MCT1是多发性骨髓瘤来那度胺维持治疗的预测标志物

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2021005532
Stroh, Jacob; Seckinger, Anja; Heider, Michael; Rudelius, Martina; Eichner, Ruth; Schick, Markus; Slawska, Jolanta; Emde-Rajaratnam, Martina; Salwender, Hans; Bertsch, Uta; Goldschmidt, Hartmut; Weisel, Katja; Scheid, Christof; Keller, Ulrich; Hose, Dirk; Bassermann, Florian
多发性骨髓瘤
骨髓瘤
发表日期：2022
文献求助 收藏